Strategic Market Access

Accelerating patient access to optimal care

The strategic market access team at IQVIA works to drive engagement between the NHS and the Life Science Industry to facilitate crucial discussions with key decision makers to accelerate and optimise patient access to innovative technologies. The NHS access and uptake landscape has become more complex than ever with the needs of regional populations playing a role at both a national and sub-national level.

Industry innovation should reflect the ongoing healthcare landscape. At IQVIA, we ensure that brand value propositions align with the NHS and Governments priorities 

  • To support the healthcare system in meeting ever-changing patient demands
  • By demystifying the complexities of aconstantly changing healthcare landscape
  • Supporting your organisation to positively respond to the ever-changing marketplace
offerings image

Using IQVIA’s proprietary data and in-house expertise, the team builds an understanding of the market access and healthcare policy landscape to Identify existing infrastructural barriers that may impact:

  • The adoption of new treatment
  • The target population and the current unmet need
  • The key stakeholders required to support improved adoption

All IQVIA work can be rapidly validated through our extensive network of healthcare professionals and payers.

Market Access Services

We provide end-to-end market access solutions from evidence-based strategy and value proposition to stakeholder engagement and value communication that drives patient access and uptake

Anticipate commissioners’ needs at the time of launch and generate impactful value messages. 

Such materials include, value propositions, advanced budget notifications, and budget impact models.

Comprehensive overviews of current access routes, policy drivers and commissioning landscape. Identify subnational variation in care.
Generate evidence based on proprietary and publicly available data to support the value proposition to commissioners. Create suitable evidence packs for in-field teams. To do so, the team carries out market environmental analysis to evaluate market trends as well as the NHS structure and policy.
Align customer engagement across functions, including coordinated messaging and services. Compliantly navigate local, regional and national processes and NHS structure to ensure access to therapy.
Understanding the NHS health policy landscape to support value communications with multidisciplinary customer groups, including pharma’s medical affair, market access and government affairs teams. To influence access to medicines throughout the patient pathway.

We help clients optimise their market access potential for each asset across the different stages of the product’s lifecycle

Iqvia Human data science

Powerful and Pertinent VP

Develop a value proposition that reflects and aligns with the priorities of the NHS and the Government in meeting the national healthcare agenda, using health policy and market access analysis and intelligence.

Offerings:

  • Early access strategy
  • Market environment analysis
  • Commissioner mapping, segmentation & targeting
  • Market shaping messaging
  • Commissioner & provider value propositions
  • Commissioner & KOL advisory boards / e-Delphi
group working on white board

Robust Market Access Strategy

Develop a robust market access strategy using Advanced Product / Budget Notification, highlighting the current environment using data analytics and in-house expertise. Use evidence-based strategy plan for engagement with NHSE.

Work with the UK Market Intelligence team to develop robust data analytics to provide analysis of the current landscape.

Offerings:

  • Launch strategy
  • Launch excellence checklist
  • Account targeting (activity led analysis)
  • Stakeholder engagement
  • Advanced Product / Budget Notification
group of people looking at data during business meeting

Effective Stakeholder Engagement

Use in-house expertise and field-based resourcing to develop a robust targeted stakeholder engagement list.

Communicate budget impact models and value propositions with to generate HCP champions and KOLs.

Use in-house datasets to develop a in-depth list of stakeholders working in the NHSE to inform engagement opportunities.

Offerings:

  • Pre-marketing field activities
  • Field-based training & resourcing
  • Formulary/evidence pack
  • Develop and deliver Budget Impact Models
  • Track advocacy stakeholder levels
  • Identify key drivers for sales pull through
discussing data chart

Maximise Advocacy, Adoption & Uptake

Ensure maximum adoption of uptake post launch, IQVIA will continue to assess the ever changing landscape to ensure value propositions remains aligned to NHS and Government priorities and address current unmet needs.

Offerings:

  • Post launch uptake analysis
  • Competitor pipeline assessment
  • RWD generation to support reimbursement
  • Landscape change impact assessment
  • Updating VP to drive uptake

Life-cycle Management

Support and manage the brand’s late lifecycle (i.e., after loss of exclusivity), in order to realise the product’s full medical and commercial value.

Assess commissioning policies and commercial access schemes, and develop evidence-based market access strategy for products in late lifecycle.

Offerings:

  • LOE planning
  • Commissioning policies
  • Contracting and tendering
  • Commercial access schemes
Market Access is doing everything necessary to ensure medicines and medical health technologies are available to clinicians when the patient needs them.

NEIL BUNKER, SENIOR CONSULTANT
“What is Market Access?” IQVIA Blog

Contact Us